TD Cowen Maintains Outperform on TransMedics Gr, Raises Price Target to $110
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Joshua Jennings maintains an Outperform rating on TransMedics Gr (NASDAQ:TMDX) and raises the price target from $95 to $110.
August 04, 2023 | 4:47 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TD Cowen analyst maintains an Outperform rating on TransMedics Gr and raises the price target from $95 to $110.
The news of TD Cowen maintaining an Outperform rating and raising the price target for TransMedics Gr is likely to have a positive impact on the company's stock in the short term. This is because such news often leads to increased investor confidence, which can drive up the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100